Townsend Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.86K Hold
52
﹤0.01% 175
2026
Q1
$8.76K Hold
52
﹤0.01% 169
2025
Q4
$8.74K Hold
52
﹤0.01% 155
2025
Q3
$7.47K Hold
52
﹤0.01% 152
2025
Q2
$6.54K Hold
52
﹤0.01% 161
2025
Q1
$6.62K Hold
52
﹤0.01% 159
2024
Q4
$6.83K Hold
52
﹤0.01% 172
2024
Q3
$7.52K Hold
52
﹤0.01% 177
2024
Q2
$7.08K Sell
52
-54
-51% -$7.21K ﹤0.01% 176
2024
Q1
$14.6K Hold
106
0.01% 169
2023
Q4
$14.4K Hold
106
0.01% 161
2023
Q3
$12.9K Hold
106
0.01% 159
2023
Q2
$13.4K Hold
106
0.01% 168
2023
Q1
$13.7K Hold
106
0.01% 171
2022
Q4
$13.9K Hold
106
0.01% 173
2022
Q3
$12K Hold
106
0.01% 170
2022
Q2
$12K Hold
106
0.01% 188
2022
Q1
$14K Buy
106
+1
+1% +$130 0.01% 185
2021
Q4
$16K Hold
105
0.01% 186
2021
Q3
$17K Hold
105
0.01% 181
2021
Q2
$17K Hold
105
0.01% 173
2021
Q1
$16K Hold
105
0.01% 160
2020
Q4
$16K Hold
105
0.01% 160
2020
Q3
$14K Hold
105
0.01% 158
2020
Q2
$14K Hold
105
0.01% 161
2020
Q1
$11K Hold
105
0.01% 152
2019
Q4
$13K Buy
+105
New +$11.7K 0.01% 172

Other funds holding IBB

Townsend Asset Management's IBB Position: Q2 2026 in Review

Townsend Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 52 shares worth $9.86K. The position accounts for ﹤0.01% of the portfolio, ranked #175.

Townsend Asset Management first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $17K in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Townsend Asset Management held 52 shares of iShares Biotechnology ETF worth $9.86K as of Q2 2026.
  • Townsend Asset Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Townsend Asset Management's portfolio in Q2 2026, its #175 holding.
  • Townsend Asset Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • Townsend Asset Management's iShares Biotechnology ETF position peaked at $17K in Q3 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Townsend Asset Management's 13F filing for Q2 2026, filed 24 Jul 2026.